Management of Children With Sickle Cell Disease in Europe: Current Situation and Future Perspectives-Reference-Cited by-同舟云学术

Management of Children With Sickle Cell Disease in Europe: Current Situation and Future Perspectives

Published:2016-07-28 Issue: Volume: Page:129-135
ISSN:2053-6631
Container-title:EMJ Hematology
language:
Short-container-title:EMJ Hematol

Author:

Colombatti Raffaella¹,Sainati Laura¹

Affiliation:

1. Veneto Region Reference Center for the Diagnosis and Management of Sickle Cell Disease in Childhood, Clinic of Pediatric Hematology Oncology, Department of Child and Maternal Health, Azienda Ospedaliera-University of Padova, Padova, Italy

Abstract

Sickle cell disease (SCD) is the most common haemoglobinopathy worldwide and its frequency has steadily increased in Europe in the past decades. SCD is a complex multisystem disorder characterised by chronic haemolytic anaemia, vaso-occlusive crisis, and vasculopathy. Clinical manifestations can be very different, ranging from mild haemolysis to life-threatening acute clinical complications and chronic disabilities. This review will explore service delivery across Europe to children with SCD, reporting on the available minimum standards of care and future perspectives.

Publisher

European Medical Group

Subject

General Medicine

Reference65 articles.

1. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704-12.

2. Aguilar Martinez P et al. Haemoglobinopathies in Europe: health & migration policy perspectives. Orphanet J Rare Dis. 2014;9:97.

3. Roberts I, de Montalambert M. Sickle Cell disease as a paradigm of immigration haematology: new challenges for hematologists in Europe. Haematologica. 2007;92(7):865-71.

4. de Montalembert M et al. Sickle cell disease in France in 2006: results and challenges. Arch Pediatr. 2006;13(9):1191-4.

5. Public Health England. NHS population screening: programme standards. 2010. Available at: http://www.sct.screening.nhs.uk/standardsandguidelines. Last accessed: 1 May 2016.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission;The Lancet Haematology;2023-08

2. Development of multi-level standards of care recommendations for sickle cell disease: Experience from SickleInAfrica;Frontiers in Genetics;2023-01-12

3. Treatment of Sickle Cell Disease in Sub-Saharan Africa: We have come a long way, but still have far to go;Journal of Global Medicine;2022-12-23

4. Introductory Chapter: Introduction to the History, Pathology and Clinical Management of Sickle Cell Disease;Sickle Cell Disease - Pain and Common Chronic Complications;2016-11-10